
Profile
About
Pfizer New Drug For Alopecia Areata
NEW YORK-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced positive top-line results from the Phase 2b/3 ALLEGRO trial evaluating oral once-daily ritlecitinib in patients with.
Aug 05, 2021Pfizer has reported positive top-line data from the Phase IIb/III ALLEGRO clinical trial of its drug, ritlecitinib, in alopecia areata patients. Alopecia areata is an autoimmune.
Jun 14, 2022Lilly’s Olumiant okayed in alopecia, with Pfizer, Concert in hot pursuit. Eli Lilly and Incyte’s Olumiant has secured the first FDA approval for a systemic drug to treat alopecia.
Apr 02, 2022Etrasimod, the drug developed, is an oral drug to be used once daily. Etrasimod can be used for patients suffering from immune-inflammatory diseases such as Chron’s Disease,.